Time trends in overall survival (OS) and progression-free survival (PFS) in the first-line treatment of advanced non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Rutkowski, Jacek
Saad, Everardo D.
Buyse, Marc E.
Jassem, Jacek
机构：
[1] Med Univ Gdansk, Gdansk, Poland
[2] Dendrix Res, Sao Paulo, Brazil
[3] Int Inst Drug Dev, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_supll.e20580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20580
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TRANSPORTABILITY OF OVERALL SURVIVAL ESTIMATES FROM US TO UK POPULATIONS RECEIVING FIRST-LINE TREATMENT FOR ADVANCED NON-SMALL-CELL LUNG CANCER
    Kent, S.
    Duffield, S.
    Adam, J.
    Mpofu, P.
    Beal, B.
    Royce, T.
    Adamson, B.
    Kasturi, J.
    Sujenthiran, A.
    Jonsson, P.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S364 - S364
  • [42] Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer
    Foster, Nathan R.
    Renfro, Lindsay A.
    Schild, Steven E.
    Redman, Mary W.
    Wang, Xiaofei F.
    Dahlberg, Suzanne E.
    Ding, Keyue
    Bradbury, Penelope A.
    Ramalingam, Suresh S.
    Gandara, David R.
    Shibata, Taro
    Saijo, Nagahiro
    Vokes, Everett E.
    Adjei, Alex A.
    Mandrekar, Sumithra J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) : 1099 - 1106
  • [43] First-line treatment of advanced non-small-cell lung cancer (NSCLC) with vinorelbine and cisplatin.
    Bobilev, D
    Ariad, S
    Geffen, DB
    Cohen, Y
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [44] META-ANALYSIS OF PROGRESSION-FREE SURVIVAL AND OBJECTIVE RESPONSE RATE AS PREDICTORS OF OVERALL SURVIVAL IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
    Turner, Evadne J.
    Mccloud, Philip
    Germanos, Peter
    Dehle, Francis
    Norris, Sarah
    Tan, Jonathon
    Mitchell, Paul L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S243 - S244
  • [45] BASELINE POPULATION CHARACTERISTICS AND THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ADVANCED NON SMALL CELL LUNG CANCER PATIENTS
    Kulakova, M.
    Hashim, M.
    Pfeiffer, B.
    Postma, M.
    Heeg, B.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A420 - A421
  • [46] Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer
    Garside, Jamie
    Shen, Qin
    Westermayer, Bernd
    van de Ven, Michiel
    Kroep, Sonja
    Chirikov, Viktor
    Juhasz-Boess, Ingolf
    [J]. CLINICAL THERAPEUTICS, 2023, 45 (10) : 983 - 990
  • [47] Superior overall survival (OS), progression-free survival (PFS), and clinical response (CR) predictions for patients with non-small cell lung cancer (NSCLC) using Cellworks Singula: myCare-022-05.
    Velcheti, Vamsidhar
    Castro, Michael
    Watson, Drew
    Kapoor, Shweta
    Tyagi, Anuj
    Sauban, Mohammed
    Alam, Aftab
    Roy, Kunal Ghosh
    Rajagopalan, Swaminathan
    Kulkarni, Shruthi
    Mundkur, Nirjhar
    Christie, Jim
    Suseela, Rakhi Purushothaman
    Ghosh, Adity
    Basu, Kabya
    Sahu, Diwyanshu
    Ullal, Yashaswini
    Nair, Prashant
    Ahluwalia, Manmeet Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
    Apurva Singh
    Hannah Horng
    Leonid Roshkovan
    Joanna K. Weeks
    Michelle Hershman
    Peter Noël
    José Marcio Luna
    Eric A. Cohen
    Lauren Pantalone
    Russell T. Shinohara
    Joshua M. Bauml
    Jeffrey C. Thompson
    Charu Aggarwal
    Erica L. Carpenter
    Sharyn I. Katz
    Despina Kontos
    [J]. Scientific Reports, 12 (1)
  • [49] Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
    Singh, Apurva
    Horng, Hannah
    Roshkovan, Leonid
    Weeks, Joanna K.
    Hershman, Michelle
    Noel, Peter
    Luna, Jose Marcio
    Cohen, Eric A.
    Pantalone, Lauren
    Shinohara, Russell T.
    Bauml, Joshua M.
    Thompson, Jeffrey C.
    Aggarwal, Charu
    Carpenter, Erica L.
    Katz, Sharyn, I
    Kontos, Despina
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01):
  • [50] Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer
    Szentkereszty, Marton
    Komlosi, Zsolt Istvan
    Szucs, Gergo
    Barna, Gabor
    Tamasi, Lilla
    Losonczy, Gyorgy
    Galffy, Gabriella
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 1117 - 1128
12345